04/02/2013
https://congress.gov...
"We have a huge opportunity to incentivize them."
"I hate to cut this off, but this has been the best interaction we have had with members and witnesses."
"the cost of developing a drug has doubled, as has the number of clinical trials necessary to file a new drug application."
"I urge my colleagues to take swift action and aggressive action because we do not have a moment to waste."